Benzinga Neuro Why Is Gene Therapy-Focused Intellia Therapeutics Stock Trading Lower On Thursday? Intellia Therapeutics' Phase 2 data shows NTLA-2002, a CRISPR gene therapy, reduced hereditary ...
Cellworks Group Inc., a leader in Personalized Therapy Decision Support and Precision Drug Development, today announced results from a study demonstrating the efficacy of the Cellworks Therapy ...
As someone who reads over 50 books a year, I’ve curated a list of the absolute best gifts you can buy book lovers. From page ...
“In the third quarter, we continued to advance the development of our investigational cellular therapy candidate, Lomecel-B™, ...
Dr. Abrishami says lonely people may avoid responding to texts, let enough time lapse that the message is no longer relevant, ...
High-risk youth who have felt targeted by the incoming administration may be at increased risk for self-harm. Here's how ...
Company continues to focus on upcoming results from ENLIGHTEN 2 pivotal Phase 3 trial in CRS patients expected in 2Q 2025 Company reports topline safety results from ENLIGHTEN 1 Phase 3 extension ...
Legal Battle Brews Over 23andMe's Customer Data Breach Settlement And Arbitration Claimants Lawyer raises objections to 23andMe's proposed $30 million settlement, arguing it undermines arbitration ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback